AIM ImmunoTech Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2014 | $-14.0M | $-14.5M | $504.0K | $223.0K |
| FY2015 | $-16.1M | $-16.3M | $240.0K | $121.0K |
| FY2016 | $-7.4M | $-7.5M | $160.0K | $52.0K |
| FY2017 | $-7.9M | $-8.0M | $20.0K | $571.0K |
| FY2018 | $-10.6M | $-10.7M | $51.0K | $929.0K |
| FY2019 | $-9.1M | $-9.1M | $68.0K | $853.0K |
| FY2020 | $-10.4M | $-10.4M | $22.0K | $1.0M |
| FY2021 | $-14.0M | $-14.0M | $41.0K | $1.6M |
| FY2022 | $-16.1M | $-16.2M | $86.0K | $954.0K |
| FY2023 | $-21.3M | $-21.3M | — | $243.0K |